Total Raised

$190.25M

Investors Count

12

Deal Terms

1

Funding, Valuation & Revenue

16 Fundings

MicroTransponder has raised $190.25M over 16 rounds.

MicroTransponder's latest funding round was a Series F for $65M on March 12, 2025.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/12/2025

Series F

$65M

$XXM

0

FY undefined

3

11/17/2023

Biz Plan Competition

$0.2M

$XXM

0

FY undefined

1

6/6/2023

Incubator/Accelerator

$XXM

0

FY undefined

1

6/20/2022

Series E

$XXM

$XXM

0

FY undefined

10

7/30/2021

Debt - III

$XXM

$XXM

0

FY undefined

10

Date

3/12/2025

11/17/2023

6/6/2023

6/20/2022

7/30/2021

Round

Series F

Biz Plan Competition

Incubator/Accelerator

Series E

Debt - III

Amount

$65M

$0.2M

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

1

1

10

10

Start free trial
New call-to-action

MicroTransponder Deal Terms

1 Deal Term

MicroTransponder's deal structure is available for 1 funding round, including their Series B from June 12, 2012.

Round

Series B

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

MicroTransponder Investors

12 Investors

MicroTransponder has 12 investors. Green Park & Golf Ventures invested in MicroTransponder's Series F funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/29/2013

3/12/2025

4
Series B - II, Series C (2015), Series E (2022), Series F (2025)

Venture Capital

Texas

6/20/2022

3/12/2025

2
Series E, Series F (2025)

Family Office

Texas

6/20/2022

3/12/2025

2
Series E, Series F (2025)

Venture Capital

California

00/00/0000

00/00/0000

Osage University Partners

Subscribe to see more

Venture Capital

Pennsylvania

00/00/0000

00/00/0000

The Vertical Group

Subscribe to see more

Venture Capital

New Jersey

First funding

8/29/2013

6/20/2022

6/20/2022

00/00/0000

00/00/0000

Last Funding

3/12/2025

3/12/2025

3/12/2025

00/00/0000

00/00/0000

Investor

Osage University Partners

The Vertical Group

Rounds

4
Series B - II, Series C (2015), Series E (2022), Series F (2025)
2
Series E, Series F (2025)
2
Series E, Series F (2025)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Family Office

Venture Capital

Venture Capital

Venture Capital

Location

Texas

Texas

California

Pennsylvania

New Jersey

New call-to-action

Compare MicroTransponder to Competitors

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

S
Spinal Restoration

Spinal Restoration is involved in the development of therapies for chronic low back pain within the healthcare sector. The company's main offering is the Biostat4 System, a non-surgical procedure aimed at addressing chronic low back pain. Spinal Restoration serves the healthcare industry, with an emphasis on spinal health management. It was founded in 2004 and is based in Austin, Texas.

D
DuoCore

DuoCure offers intraluminal minimally invasive implantable device for treatment of obesity.

Endologix Logo
Endologix

Endologix develops and manufactures minimally invasive treatments for vascular diseases in the medical device industry. The company offers endovascular stent grafts designed to treat abdominal aortic aneurysms (AAA) and provides solutions for aortic disorders. Endologix also provides virtual reality procedural training for physicians to enhance their skills in vascular interventions. It was founded in 1992 and is based in Irvine, California.

C
CryoPen

CryoPen is a company focused on advancing cryosurgical technology within the medical device industry. Its main offering is the CryoPen Surgical System, which employs linear compression cooling technology to perform cryosurgery using cryogenic gases or liquids. The system is designed for precision treatment of various skin lesions and pre-cancerous conditions, catering primarily to medical professionals in fields such as general practice, OB/GYN, podiatry, internal medicine, urology, and pediatrics. It was founded in 2005 and is based in Corpus Christi, Texas.

D
Disc Dynamics

Disc Dynamics is an orthopedic spine company that provides surgical alternatives for degenerative disc disease. The company offers the DASCOR® Disc Arthroplasty System, which is a catheter-based technology designed to replace the nucleus of degenerated lumbar discs. This system is intended to relieve pain and restore function while preserving the anatomy of the spine. It was founded in 2000 and is based in Eden Prairie, Minnesota.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.